# MOLECULARMD CORP.: Form D filings

MOLECULARMD CORP., a biotechnology company in Portland, OR, filed 5 Form D notices with the SEC between 2012 and 2017. The latest, on February 10, 2017, reports $2.1 million sold of a $2.1 million offering to 7 investors.

Find out what MOLECULARMD CORP. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20MOLECULARMD%20CORP.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=MOLECULARMD%20CORP.&page=%2Fdata%2Fform-d%2Fcompany%2Fmolecularmd-corp-1542181)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20MOLECULARMD%20CORP.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=MOLECULARMD%20CORP.&page=%2Fdata%2Fform-d%2Fcompany%2Fmolecularmd-corp-1542181)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Oregon](https://specstream.ai/data/form-d/state/oregon): 434 rows, by operating companies, filed since November 1, 2024, $21.70, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/oregon
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 1341 SW CUSTER DRIVE, Portland, OR, 97219
- Phone: (503) 459-4974
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1542181

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Feb 10, 2017 | New notice | $2,070,300 | $2,070,300 | $0 | 7 | Jan 31, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1542181/000154218117000001/0001542181-17-000001-index.htm) |
| Jul 18, 2016 | New notice | $2,000,000 | $500,000 | $1,500,000 | 6 | Jul 5, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1542181/000154218116000003/0001542181-16-000003-index.htm) |
| May 20, 2013 | New notice | $2,500,000 | $2,500,000 | $0 | 4 | May 3, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1542181/000154218113000001/0001542181-13-000001-index.htm) |
| Apr 5, 2012 | Amendment | $9,000,000 | $8,000,000 | $1,000,000 | 6 | Feb 3, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1542181/000154218112000002/0001542181-12-000002-index.htm) |
| Feb 15, 2012 | New notice | $8,000,000 | $8,000,000 | $0 | 4 | Feb 3, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1542181/000154218112000001/0001542181-12-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Chad G. Galderisi | Executive Officer |  |
| Sheridan D. Snyder | Executive Officer, Director |  |
| Sheridan G. Snyder | Director |  |
| Matthew G. Rice | Director |  |
| Frederick G. Eibel | Executive Officer |  |
| Ryan G. Dunlap | Executive Officer |  |
| Peter G. Maag | Director |  |
| Cindy G. Spittle | Executive Officer |  |
| Drew G. Graham | Director |  |

## Other biotechnology companies in Oregon that filed recently

- [UBIVAC, INC.](https://specstream.ai/data/form-d/company/ubivac-inc-1713945) $80,000 · Aug 27, 2026
- [Trace Biosciences Inc.](https://specstream.ai/data/form-d/company/trace-biosciences-inc-2147501) $8.3 million · Aug 12, 2026

[Every Form D from the week of Feb 6, 2017](https://specstream.ai/data/form-d/week/2017-02-06) · [All recent filings in Oregon](https://specstream.ai/data/form-d/state/oregon) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what MOLECULARMD CORP. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).